{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:42:31Z","timestamp":1760550151459},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.remn.2016.08.002","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T17:47:05Z","timestamp":1477417625000},"page":"78-84","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The value of quantitative analysis in 18F-NaF PET\/CT"],"prefix":"10.1016","volume":"36","author":[{"given":"P.","family":"Lapa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2016.08.002_bib0130","first-page":"1356","article-title":"Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities","volume":"46","author":"Even-Sapir","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3413\/Nukmed-0727-15-02","article-title":"18F-FDG PET\/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET\/CT","volume":"54","author":"Piccardo","year":"2015","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.remn.2016.08.002_bib0140","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1097\/RLU.0b013e3182815f64","article-title":"Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET\/CT, 18F FDG PET\/CT and whole-body MRI for detection of skeletal metastases","volume":"38","author":"Iagaru","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/RLU.0000000000000592","article-title":"Performance of 18F-fluoride PET or PET\/CT for the detection of bone metastases: a meta-analysis","volume":"40","author":"Shen","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0150","first-page":"1800","article-title":"Prospective evaluation of the clinical value of planar bone scans, SPECT, and 18F-labeled NaF PET in newly diagnosed lung cancer","volume":"42","author":"Schirrmeister","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0155","first-page":"53","article-title":"Radiological imaging for the diagnosis of bone metastases","volume":"45","author":"Rybak","year":"2001","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0160","first-page":"1431","article-title":"Understanding the standardized uptake value, its methods, and implications for usage","volume":"45","author":"Thie","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0165","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1097\/RLU.0000000000000633","article-title":"18F-sodium fluoride PET\/CT in oncology: an atlas of SUVs","volume":"40","author":"Sabbah","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0170","doi-asserted-by":"crossref","first-page":"e108429","DOI":"10.1371\/journal.pone.0108429","article-title":"Normal SUV values measured from NaF18-PET\/CT bone scan studies","volume":"9","author":"Win","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.remn.2016.08.002_bib0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1590\/0100-3984.2014.0119","article-title":"Receiver operating characteristic (ROC) curve for classification of 18F-NaF uptake on PET\/CT","volume":"49","author":"Valadares","year":"2016","journal-title":"Radiol Bras"},{"key":"10.1016\/j.remn.2016.08.002_bib0180","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.semnuclmed.2007.07.002","article-title":"18F-Fluoride positron emission tomography and positron emission tomography\/computed tomography","volume":"37","author":"Even-Sapir","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2011.09.053","article-title":"Clinical utility of 18F-fluoride PET\/CT in benign and malignant bone diseases","volume":"50","author":"Li","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.remn.2016.08.002_bib0190","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s00259-012-2195-8","article-title":"18F-Fluoride PET\/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy","volume":"39","author":"Bortot","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.08.002_bib0195","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11604-013-0179-7","article-title":"The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET\/CT and 99mTc-MDP bone scan","volume":"31","author":"Damle","year":"2013","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.remn.2016.08.002_bib0200","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1148\/rg.345130061","article-title":"Newer PET application with an old tracer: role of 18F-NaF skeletal PET\/CT in oncologic practice","volume":"34","author":"Bastawrous","year":"2014","journal-title":"Radiographics"},{"key":"10.1016\/j.remn.2016.08.002_bib0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.semnuclmed.2004.11.005","article-title":"Positron emission tomography and bone metastases","volume":"35","author":"Fogelman","year":"2005","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0210","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-Fluoride PET, and 18F-Fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13139-012-0178-0","article-title":"Usefulness of 18F-fluoride PET\/CT in breast cancer patients with osteosclerotic bone metastases","volume":"47","author":"Yoon","year":"2013","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.08.002_bib0220","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","article-title":"Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions","volume":"16","author":"Cook","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2016.08.002_bib0225","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/MNM.0b013e3283512adb","article-title":"Comparison of six quantitative methods for the measurement of bone turnover at the hip and lumbar spine using 18F-fluoride PET-CT","volume":"33","author":"Puri","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remn.2016.08.002_bib0230","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy","volume":"31","author":"Kinahan","year":"2010","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.remn.2016.08.002_bib0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2191-219X-1-4","article-title":"18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)","volume":"1","author":"Cook","year":"2011","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.remn.2016.08.002_bib0240","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2967\/jnumed.113.135269","article-title":"Quantification of 18F-Fluoride kinetics: evaluation of simplified methods","volume":"55","author":"Raijmakers","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.08.002_bib0245","first-page":"162","article-title":"Differentiation of metastatic vs. degenerative joint disease using semi-quantitative analysis with 18F-NaF PET\/CT in castrate resistant prostate cancer patients","volume":"5","author":"Muzahir","year":"2015","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.08.002_bib0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cpet.2014.03.003","article-title":"18F-fluoride PET\/computed tomography imaging","volume":"9","author":"Even-Sapir","year":"2014","journal-title":"PET Clin"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X1630138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X1630138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T03:55:32Z","timestamp":1536292532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X1630138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2253654X1630138X"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2016.08.002","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of quantitative analysis in 18F-NaF PET\/CT","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2016.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}